#mySK Shelley Vogler Senior Production Planner profiled by SK Group
Link to Original Post: https://www.linkedin.com/posts/sk-group-media_mysk-activity-6889210467521196032-pLZT
Uncategorized
ChimicaOggi|ChemToday Interview with Aslam Malik
A word with…Aslam Malik PhD, CEO SK pharmteco After the acquisition of Yposkesi that allowed SK pharmteco to enter the Cell and Gene Therapy market, are there any other expansion plans you would like to highlight? This is an exciting area for us. Our goal is to become the largest global, end to end …
ChimicaOggi|ChemToday Interview with Aslam Malik Read More »
CPhI Milan 2021
Attending CPhI? Pop by Stand 2C46 to meet SK pharmteco’s Pedro Couto Rosado Director of Business Development and Yposkesi’s Dr Brian Mullan Head of Analytical and Process Development, Innovation, Cell and Gene Therapies to hear about #skpharmteco‘s global offering in cell and gene therapy – lentiviral vectors, adeno-associated viral vectors, continuous flow processing, chromatography, SMB, HPAPI, energetic chemistry, controlled substances …
Handling HPAPIs for maximum manufacturing flexibility while maintaining adequate safety controls
Click below to read an article published in the latest issue of tks | publisher, event organiser, media agency written by #SKpharmteco VP Research & Development William DuBay and SK biotek Ireland Limited Director of R&D Samuel Baron focused on ‘Handling HPAPIs for maximum manufacturing flexibility while maintaining adequate safety controls’. https://www.teknoscienze.com/tks_article/handling-hpapis-for-maximum-manufacturing-flexibility-while-maintaining-adequate-safety-controls/